2-(pyridin-2-yl)-4-(trifluoromethyl)phenol | 33400-80-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(pyridin-2-yl)-4-(trifluoromethyl)phenol
• 英文别名: Phenol, 2-(2-pyridinyl)-4-(trifluoromethyl)-；2-pyridin-2-yl-4-(trifluoromethyl)phenol
• CAS: 33400-80-5
• 化学式: C₁₂H₈F₃NO
• 分子量: 239.197
• InChiKey: YQTPPZSJVOSNNS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  33.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [4-(3-Methanesulfonyloxy-butoxy)-3-methyl-phenyl]-acetic acid methyl ester 、 2-(pyridin-2-yl)-4-(trifluoromethyl)phenol 以to afford 0.118 g (61%) of (R)-{3-methyl-4-[3-(2-pyridin-2-yl-4-trifluoromethyl-phenoxy)-butoxy]-phenyl}-acetic acid的产率得到(R)-{3-methyl-4-[3-(2-pyridin-2-yl-4-trifluoromethyl-phenoxy)-butoxy]-phenyl}-acetic acid
  参考文献：
  名称：

  Ppar modulators

  摘要：

  本发明涉及一种化合物I，或其药学上可接受的盐、溶剂化物、水合物或立体异构体，其在治疗或预防由过氧化物酶体增殖激活受体（PPAR）介导的疾病方面具有用途，例如X综合征、2型糖尿病、高血糖、高脂血症、肥胖症、凝血障碍、高血压、动脉硬化以及其他与X综合征和心血管疾病有关的疾病。

  公开号：

  US20060257987A1
• 作为产物：
  描述：

  2-(3-trifluoromethylphenyl)pyridine 在 双(乙腈)氯化钯(II) 、 氧气 、 丙醛 作用下， 以 1,2-二氯乙烷 为溶剂， 100.0 ℃ 、101.33 kPa 条件下， 以63%的产率得到2-(pyridin-2-yl)-4-(trifluoromethyl)phenol
  参考文献：
  名称：

  醛自氧化诱导钯催化的2-芳基吡啶有氧直接C（sp2）-H羟基化

  摘要：

  本文中，我们介绍了使用分子氧（O 2）作为唯一氧化剂的Pd催化2-芳基吡啶的直接C–H羟基化反应。该方法的关键方面包括：（a）用无毒且廉价的醛活化分子氧；（b）原位产生的酰基过氧自由基与钯催化的有效结合；（c）方便的操作条件。基于一系列对照实验中获得的结果，涉及Pd II / Pd IV催化循环的转化。此外，该方法可容易地以良好的分离产率获得广泛范围的取代的2-（吡啶-2-基）苯酚。

  DOI：

  10.1021/acscatal.6b01539

文献信息

• [EN] SULFONAMIDE COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS<br/>[FR] COMPOSÉS SULFONAMIDES COMME MODULATEURS DES CANAUX SODIQUES POTENTIEL-DÉPENDANTS
  申请人：LUPIN LTD

  公开号：WO2015151001A1

  公开（公告）日：2015-10-08

  The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. It further relates to the compounds herein and their pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof useful in treating diseases, disorders, syndromes and/or conditions associated with the inhibition of Voltage-gated sodium channels (VGSC) particularly NaV1.7. The invention also relates to process for the preparation of the compounds of the invention.

  本发明涉及式（I）的化合物，其中取代基如本文所述，并且它们在治疗与抑制电压门控钠通道（VGSC）特别是NaV1.7相关的疾病的药物中的使用。它进一步涉及本文中的化合物及其药学上可接受的盐，以及在治疗与抑制电压门控钠通道（VGSC）特别是NaV1.7相关的疾病、疾病、综合症和/或症状中有用的药物组合物。该发明还涉及制备本发明化合物的方法。
• [EN] PPAR MODULATORS<br/>[FR] MODULATEURS DU RECEPTEUR ACTIVE DE LA PROLIFERATION DES PEROXYSOMES (PPAR)
  申请人：LILLY CO ELI

  公开号：WO2005019151A1

  公开（公告）日：2005-03-03

  The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.

  本发明涉及一种具有式I的化合物，或其药学上可接受的盐、溶剂合物、水合物或立体异构体，该化合物在治疗或预防由过氧化物酶体增殖物激活受体（PPAR）介导的疾病中具有用途，如X综合征、2型糖尿病、高血糖、高脂血症、肥胖、凝血障碍、高血压、动脉硬化以及与X综合征和心血管疾病相关的其他疾病。
• Design and synthesis of ruthenium bipyridine catalyst: An approach towards low-cost hydroxylation of arenes and heteroarenes
  作者：Sanchari Shome、Surya Prakash Singh

  DOI：10.1016/j.tetlet.2017.08.037

  日期：2017.9

  Two new ruthenium bipyridine complexes were designed and synthesized for intermolecular Csp2-H hydroxylation. An environmentally begin and inexpensive oxidant was employed as an oxygen source thereby enhancing its applicability and resulting in the remarkable increase of yield. In the catalytic process a ruthenium (IV) cationic complex is formed which enables the regioselective CO bonds formation and

  设计并合成了两种新的钌联吡啶复合物用于分子间Csp 2 -H羟基化。采用一种环境友好的廉价氧化剂作为氧源，从而提高了其适用性，并显着提高了收率。在催化过程中，形成了钌（IV）阳离子络合物，该络合物能够形成区域选择性的C O键，并且被证明对宽泛的底物范围具有耐受性。已经有效地研究了与可移动和不可移动的导向基团相邻的C H键的活化。
• Palladium-Catalyzed Aryl C(sp²)–H Bond Hydroxylation of 2-Arylpyridine Using TBHP as Oxidant
  作者：Jiawei Dong、Ping Liu、Peipei Sun

  DOI：10.1021/acs.joc.5b00167

  日期：2015.3.6

  An efficient synthesis of phenols via Pd-catalyzed, pyridyl-directed homogeneous hydroxylation of the aryl C-H bond was developed, in which tert-butyl hydroperoxide was used as the sole oxidant. The method had a broad group tolerance and was available for both electron-rich and electron-deficient substrates. The reaction of a series of 2-arylpyridine derivatives gave the ortho-hydroxylation products in moderate to good yields.
• Design and synthesis of a novel class of dual PPARγ/δ agonists
  作者：Isabel C. Gonzalez、Jason Lamar、Fatima Iradier、Yanping Xu、Leonard L. Winneroski、Jeremy York、Nathan Yumibe、Richard Zink、Chahrzad Montrose-Rafizadeh、Gary J. Etgen、Carol L. Broderick、Brian A. Oldham、Nathan Mantlo

  DOI：10.1016/j.bmcl.2006.11.029

  日期：2007.2

  The design and synthesis of dual PPAR 7/8 agonist (R)-3-2-ethyl-4-[3-(4-ethyl-2-pyridin-2-yl-phenoxy)-butoxy]-phenyl}propionic acid is described. This compound dose-dependently lowered plasma glucose in hyperglycemic male Zucker diabetic fatty (ZDF) rats and produced less weight gain relative to rosiglitazone at an equivalent level of glucose control. (c) 2006 Elsevier Ltd. All rights reserved.